Clinical trialNCT05143996RecruitingPhase 1Interventional

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

SponsorCullinan Therapeutics Inc.Enrollment60Myelodysplastic Syndrome (MDS)Relapsed/Refractory Acute Myeloid Leukemia (AML)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama O'Neal Cancer Center
Birmingham, Alabama, United States
Kimo Bachiashvili, MD
Recruiting
Ucla
Los Angeles, California, United States
Gary Schiller
Recruiting
University of Miami Health System
Miami, Florida, United States
Namrata Chandhok, MD
Recruiting
Moffitt Cancer Center
Tampa, Florida, United States
Onyee Chan
Recruiting
Emory University Hospital
Atlanta, Georgia, United States
William Blum
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Completed
Roswell Park Cancer Institute
Buffalo, New York, United States
Eunice Wang, MD
Recruiting
New York University
New York, New York, United States
Mohammad Maher Abdul Hay
Recruiting
Duke Cancer Center
Durham, North Carolina, United States
Sanghee Hong, MD
Recruiting
Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Withdrawn
Md Anderson
Houston, Texas, United States
Ghayas Issa
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Nov 2021
Primary completion: 31 Jan 2027
Completion: 30 Jun 2027
Last update posted: 16 Jan 2026
Registered enrollment: 60
Registry id: NCT05143996

Cross-registrations

EU-CTR / CTIS (EudraCT)2020-005195-35

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.